<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2018.9277</article-id>
<article-id pub-id-type="publisher-id">mmr-18-03-2789</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Integrative analysis of promising molecular biomarkers and pathways for coronary artery disease using WGCNA and MetaDE methods</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Yan</surname><given-names>Shilin</given-names></name>
<xref rid="af1-mmr-18-03-2789" ref-type="aff"/>
<xref rid="c1-mmr-18-03-2789" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-mmr-18-03-2789">Department of Cardiology, Yangling Demonstration Zone Hospital, Xianyang, Shaanxi 712100, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-18-03-2789"><italic>Correspondence to</italic>: Dr Shilin Yan, Department of Cardiology, Yangling Demonstration Zone Hospital, Yangling Zone, 8 Houji Road, Xianyang, Shaanxi 712100, P.R. China, E-mail: <email>yanshilin128@sina.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub"><month>09</month><year>2018</year></pub-date>
<pub-date pub-type="epub"><day>16</day><month>07</month><year>2018</year></pub-date>
<volume>18</volume>
<issue>3</issue>
<fpage>2789</fpage>
<lpage>2797</lpage>
<history>
<date date-type="received"><day>08</day><month>01</month><year>2018</year></date>
<date date-type="accepted"><day>31</day><month>05</month><year>2018</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Yan et al.</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>The present study aimed to examine the molecular mechanisms of coronary artery disease (CAD). A total of four microarray datasets (training dataset no. GSE12288; validation dataset nos. GSE20680, GSE20681 and GSE42148) were downloaded from the Gene Expression Omnibus database, which included CAD and healthy samples. Weighted gene co-expression network analysis was applied to identify highly preserved modules across the four datasets. Differentially expressed genes (DEGs) with significant consistency in the four datasets were selected using the MetaDE method. The overlapping genes amongst the DEGs with significant consistency and in the preserved modules were used to construct a protein-protein interaction (PPI) network, followed by functional enrichment analysis. A total of 11 modules were established in the training dataset, and five of them were highly preserved across all four datasets, including 873 genes. There was a total of 836 DEGs with significant consistency in the four datasets. A total of 177 overlapping genes were selected, with which a PPI network was constructed. The top five genes of the PPI network were identified based on their degrees: LCK proto-oncogene, Src family tyrosine kinase (<italic>LCK</italic>), euchromatic histone lysine methyltransferase 2 (<italic>EHMT2</italic>), inosine monophosphate dehydrogenase 2 (<italic>IMPDH2</italic>), protein phosphatase 4 catalytic subunit (<italic>PPP4C</italic>) and &#x03B6;-chain of T-cell receptor associated protein kinase 70 (<italic>ZAP70</italic>). Genes in the PPI network were significantly involved in a number of Kyoto Encyclopedia Genes and Genomes pathways, including the &#x2018;natural killer cell mediated cytotoxicity&#x2019;, &#x2018;primary immunodeficiency&#x2019; and &#x2018;Fc gamma R-mediated phagocytosis&#x2019; pathways. <italic>LCK, EHMT2, IMPDH2, PPP4C</italic> and <italic>ZAP70</italic> are suggested as promising molecular biomarkers for CAD. The &#x2018;natural killer cell mediated cytotoxicity&#x2019;, &#x2018;primary immunodeficiency&#x2019; and &#x2018;Fc gamma R-mediated phagocytosis&#x2019; pathways may serve important roles in CAD.</p>
</abstract>
<kwd-group>
<kwd>weighted gene co-expression network</kwd>
<kwd>coronary artery disease</kwd>
<kwd>network</kwd>
<kwd>module</kwd>
<kwd>pathway</kwd>
<kwd>protein-protein interaction</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Coronary artery disease (CAD) remains one of the most common causes of morbidity and mortality globally, with an increased prevalence predicted in the near future (<xref rid="b1-mmr-18-03-2789" ref-type="bibr">1</xref>). The occurrence of CAD events is primarily due to crosstalk between genetic and environmental factors (<xref rid="b2-mmr-18-03-2789" ref-type="bibr">2</xref>). A number of risk factors of CAD have been identified, including smoking, obesity and family history (<xref rid="b3-mmr-18-03-2789" ref-type="bibr">3</xref>). Available treatment options primarily include lifestyle alterations, medical treatment and surgical interventions, which are chosen depending on comorbidities and the preferences of the individual patient (<xref rid="b4-mmr-18-03-2789" ref-type="bibr">4</xref>). Prevention and treatment of this disease remains a daunting task. Therefore, further research is required to elucidate the underlying biological features for the development of more adequate therapy for patients.</p>
<p>The rapid prevalence of high-throughput microarray technologies has facilitated identification of genome variations in diseases, contributing to a deeper understanding of pathogenesis and the development of promising biomarkers (<xref rid="b5-mmr-18-03-2789" ref-type="bibr">5</xref>,<xref rid="b6-mmr-18-03-2789" ref-type="bibr">6</xref>). Such technologies have been applied to investigate the underlying mechanisms of CAD. Ren <italic>et al</italic> (<xref rid="b7-mmr-18-03-2789" ref-type="bibr">7</xref>) identified a circulating micro (mi)RNA signature for CAD using co-expression network analyses on miRNA array data. In addition, a study of genomic DNA methylation profiling in patients with CAD was conducted (<xref rid="b8-mmr-18-03-2789" ref-type="bibr">8</xref>). Furthermore, Liu <italic>et al</italic> (<xref rid="b9-mmr-18-03-2789" ref-type="bibr">9</xref>) performed a secondary analysis using a weighted gene co-expression network (WGCNA) on microarray data of CAD samples (dataset no. GSE23561), which were downloaded from the Gene Expression Omnibus (GEO) database. It was identified that the glucose-6-phosphate 1-dehydrogenase, protein S100-A7 and hypertrophic cardiomyopathy pathways were involved in CAD (<xref rid="b9-mmr-18-03-2789" ref-type="bibr">9</xref>). However, this previous study had the limitation of sample size (six CAD samples and nine normal samples).</p>
<p>Therefore, four microarray datasets of CAD from the GEO database were included in the present study. WGCNA was used to construct a co-expression network and the highly preserved modules in the four datasets were determined. The MetaDE method in R language, which is capable of conducting 12 primary meta-analysis methods (<xref rid="b10-mmr-18-03-2789" ref-type="bibr">10</xref>), has been utilized for the detection of differentially expressed genes (DEGs) in a number of diseases, including gastric cancer (<xref rid="b11-mmr-18-03-2789" ref-type="bibr">11</xref>) and colorectal cancer (<xref rid="b12-mmr-18-03-2789" ref-type="bibr">12</xref>). In the present study, the DEGs with significant consistency across all four datasets were selected using the MetaDE method and subsequently compared with the genes in the highly preserved WGCNA modules. Subsequently, the overlapping genes were used to construct a protein-protein interaction (PPI) network, followed by functional analysis of the genes in the network. The in-depth analysis conducted in the present study may provide novel insights into the pathogenesis of CAD.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Microarray data</title>
<p>Microarray data for CAD were searched in NCBI GEO (<uri xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</uri>). Inclusion criteria were: i) The dataset belonged to a gene expression profile; ii) samples in the dataset were collected from blood; iii) the samples included patients and healthy controls; iv) the dataset was based on human gene expression profiles; and v) the sample number was &#x2265;20. A total of four datasets, GSE12288 (n=222; CAD, 112; control, 110) (<xref rid="b13-mmr-18-03-2789" ref-type="bibr">13</xref>), GSE20680 (n=139; CAD, 87; control, 52) (<xref rid="b14-mmr-18-03-2789" ref-type="bibr">14</xref>), GSE20681 (n=198; CAD, 99; control, 99) (<xref rid="b15-mmr-18-03-2789" ref-type="bibr">15</xref>) and GSE42148 (n=24; CAD, 13; control, 11; <uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42148">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42148</uri>) that met the criteria were included in the present study (<xref rid="tI-mmr-18-03-2789" ref-type="table">Table I</xref>).</p>
</sec>
<sec>
<title>Data preprocessing</title>
<p>Raw data in CEL files from GSE12288 were downloaded from the Affy platform (<uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GPL96">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GPL96</uri>) and subsequently converted into gene symbols under pretreatment. The median method was used to fill in the missing values, the MicroArray Suite method to complete background correction, and the quantiles method to normalize the data, using oligo 1.41.1 in R3.3.1 language (<uri xlink:href="http://www.bioconductor.org/packages/release/bioc/html/oligo.html">http://www.bioconductor.org/packages/release/bioc/html/oligo.html</uri>) (<xref rid="b16-mmr-18-03-2789" ref-type="bibr">16</xref>). GSE20680, GSE20681 and GSE42148 were downloaded from the Agilent platform (Agilent Technologies, Inc., Santa Clara, CA, USA). Microarray raw data (TXT files) of the three datasets were log2-transformed using Limma 3.34.0 (<uri xlink:href="https://bioconductor.org/packages/release/bioc/html/limma.html">https://bioconductor.org/packages/release/bioc/html/limma.html</uri>) to achieve an approximate normal distribution, and were subsequently standardized using the median normalization method (<xref rid="b17-mmr-18-03-2789" ref-type="bibr">17</xref>).</p>
</sec>
<sec>
<title>WGCNA analysis</title>
<p>WGCNA is a well-established method for constructing scale-free gene co-expression networks, which is characterized by the use of soft thresholding (<xref rid="b18-mmr-18-03-2789" ref-type="bibr">18</xref>,<xref rid="b19-mmr-18-03-2789" ref-type="bibr">19</xref>). GSE12288 was used as the training dataset, while GSE20680, GSE20681 and GSE42148 were the validations sets. Genes with coefficients of variation &#x003C;0.1 were discarded. Correlations between the gene expression in the four datasets were evaluated with the verboseScatterplot function of the WGCNA package (<uri xlink:href="https://labs.genetics.ucla.edu/horvath/CoexpressionNetwork/Rpackages/WGCNA/">https://labs.genetics.ucla.edu/horvath/CoexpressionNetwork/Rpackages/WGCNA/</uri>). Weighted gene co-expression networks of the genes in the training dataset were constructed using the WGCNA method as previously described (<xref rid="b20-mmr-18-03-2789" ref-type="bibr">20</xref>&#x2013;<xref rid="b22-mmr-18-03-2789" ref-type="bibr">22</xref>). First, the soft threshold power of &#x03B2; was set as 18 (scale-free R<sup>2</sup>=0.9), according to the scale free topology criterion. The weighted adjacency matrix was subsequently constructed. Adjacencies and correlations were transformed into a topological overlap matrix (TOM), followed by calculating the corresponding dissimilarity (1-TOM). Subsequently, a hierarchical clustering analysis (<xref rid="b23-mmr-18-03-2789" ref-type="bibr">23</xref>) of genes was performed using 1-TOM as the distance measure. Modules were detected using dynamic tree cut algorithm with a minimum module size of 50 and a minimum cut height of 0.95. Furthermore, module preservation between the training set and the three validation sets was measured using the module preservation function of the WGCNA software package. Possible functions of the preserved module were studied using the user List Enrichment function of the WGCNA package.</p>
</sec>
<sec>
<title>Identification of DEGs with significant consistency in four datasets</title>
<p>DEGs between CAD samples and healthy controls were screened in each of the above four datasets using the metaDE method (<xref rid="b10-mmr-18-03-2789" ref-type="bibr">10</xref>,<xref rid="b24-mmr-18-03-2789" ref-type="bibr">24</xref>) in R language (<uri xlink:href="https://cran.r-project.org/web/packages/MetaDE/">https://cran.r-project.org/web/packages/MetaDE/</uri>). Heterogeneity was examined across the four datasets to assess the consistency of gene expression, by calculating tau2 and Qpval values. A tau2=0 and Qpval &#x003E;0.05 indicated that the gene was homogeneous and unbiased. The thresholds for DEG identification were tau2=0, Qpval &#x003E;0.05 and false discovery rate &#x003C;0.05. Consistency of the DEGs was detected using the MetaDE method, and the DEGs with significant consistency in the four datasets were selected for further analysis.</p>
</sec>
<sec>
<title>Construction of a PPI network</title>
<p>A PPI network was constructed to evaluate the interactions between genes in the above network. The common genes in the preserved modules that were obtained from WGCNA, and the DEGs with significant consistency, were selected to construct a PPI network based on three databases: The Biological General Repository for Interaction Datasets 3.4.153 (<uri xlink:href="http://thebiogrid.org/">http://thebiogrid.org/</uri>) (<xref rid="b25-mmr-18-03-2789" ref-type="bibr">25</xref>); the Human Protein Reference Database Release 9 (<uri xlink:href="http://www.hprd.org/">http://www.hprd.org/</uri>) (<xref rid="b26-mmr-18-03-2789" ref-type="bibr">26</xref>); and STRING 10.5 (<uri xlink:href="https://string-db.org/">https://string-db.org/</uri>) (<xref rid="b27-mmr-18-03-2789" ref-type="bibr">27</xref>). The PPIs revealed in at least two of the three databases were extracted for the PPI network, visualized using Cytoscape 3.3 software (<uri xlink:href="http://www.cytoscape.org/">http://www.cytoscape.org/</uri>) (<xref rid="b28-mmr-18-03-2789" ref-type="bibr">28</xref>). In the PPI network, a node represents a gene; the undirected link between two nodes is an edge, denoting the interaction between two genes; and the degree of a node corresponds to the number of interactions of a gene with other genes in the network.</p>
</sec>
<sec>
<title>Gene ontology (GO) functional and kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analyses</title>
<p>In order to elucidate the possible biological roles of the genes in the PPI network, GO (<xref rid="b29-mmr-18-03-2789" ref-type="bibr">29</xref>) functional and KEGG (<xref rid="b30-mmr-18-03-2789" ref-type="bibr">30</xref>) pathway enrichment analyses were performed using the Database for Annotation, Visualization and Integrated Discovery 6.8 software (<xref rid="b31-mmr-18-03-2789" ref-type="bibr">31</xref>). GO terms have three categories, including biological process (BP), cellular compartment and molecular function. P&#x003C;0.05 was considered to indicate a significant difference for GO terms and KEGG pathways.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Identification of key WGCNA modules</title>
<p>Following data preprocessing for the four datasets, the present study attempted to identify CAD-associated co-expression modules using WGCNA. Using the aforementioned methods, the correlation coefficients (CCs) of genes in the four datasets were obtained, and the CCs were 0.47&#x2013;0.92 with P-values &#x003C;1&#x00D7;10<sup>&#x2212;200</sup> between any two datasets (<xref rid="f1-mmr-18-03-2789" ref-type="fig">Fig. 1</xref>), suggesting a good consistency of the common genes across all datasets.</p>
<p>As a result, 11 co-expression modules were identified for genes in the training set using WGCNA (<xref rid="f2-mmr-18-03-2789" ref-type="fig">Fig. 2A</xref>). These modules are illustrated in branches of the dendrogram with different colors. To evaluate the robustness of these modules in the training set, the modules were re-constructed in the three validation datasets, GSE20680, GSE20681 and GSE42148, separately (<xref rid="f2-mmr-18-03-2789" ref-type="fig">Fig. 2B-D</xref>). Genes in the three validation sets were colored, according to the module color in the training set. Multi-dimensional scaling of expression data of all genes in these modules demonstrated that genes in the same module appeared to cluster together and exhibited a similar expression pattern (<xref rid="f3-mmr-18-03-2789" ref-type="fig">Fig. 3A</xref>). Additionally, hierarchical clustering analysis of these modules in the four datasets revealed that modules of the same branch tended to have similar gene expression patterns (<xref rid="f3-mmr-18-03-2789" ref-type="fig">Fig. 3B</xref>).</p>
<p>In total, five of the 11 modules, black, brown, magenta, turquoise and yellow modules, with Z-scores &#x003E;5 were determined to be well preserved across the four datasets, including 873 genes (<xref rid="tII-mmr-18-03-2789" ref-type="table">Table II</xref>). This suggested that the five highly preserved modules may be closely associated with CAD. Of the five modules, genes in the black module were significantly linked to &#x2018;response to glucocorticoid stimulus&#x2019;; those in the brown module were significantly associated with &#x2018;regulation of transcription&#x2019;; and those in the magenta module may be involved in &#x2018;protein localization&#x2019; (<xref rid="tII-mmr-18-03-2789" ref-type="table">Table II</xref>). Notably, the turquoise and the yellow module exhibited functions in &#x2018;immune response&#x2019; (<xref rid="tII-mmr-18-03-2789" ref-type="table">Table II</xref>).</p>
</sec>
<sec>
<title>Screening for DEGs with significant consistency in the four datasets</title>
<p>Using the metaDE method, 836 DEGs were identified with significant consistency across the four datasets. A heatmap for these DEGs demonstrated that the expression patterns of these DEGs differed between the CAD and control samples (<xref rid="f4-mmr-18-03-2789" ref-type="fig">Fig. 4</xref>).</p>
</sec>
<sec>
<title>Construction of a PPI network for the overlapping genes</title>
<p>A total of 177 genes were overlapping between WGCNA modules and the DEGs with significant consistency (<xref rid="f5-mmr-18-03-2789" ref-type="fig">Fig. 5A</xref>). Of them, 92 genes were included in the turquoise module, 26 in the yellow module, 16 in the black module, 31 in the brown module and 12 in the magenta module (<xref rid="f5-mmr-18-03-2789" ref-type="fig">Fig. 5B</xref>). Based on the three databases mentioned above, a PPI network was built with these overlapping genes. In total, 150 paired PPIs that appeared in at least two of the three databases were included in the PPI network (<xref rid="f6-mmr-18-03-2789" ref-type="fig">Fig. 6A</xref>), which contained 59 downregulated genes and 40 upregulated genes (<xref rid="f6-mmr-18-03-2789" ref-type="fig">Fig. 6B</xref>). All genes in the network were ranked in a descending order, according to their degrees. The top five genes were LCK proto-oncogene, Src family tyrosine kinase (<italic>LCK</italic>; degree=15), euchromatic histone lysine methyltransferase 2 (<italic>EHMT2</italic>; degree=14), inosine monophosphate dehydrogenase 2 (<italic>IMPDH2</italic>; degree=12), protein phosphatase 4 catalytic subunit (<italic>PPP4C</italic>; degree=11) and &#x03B6;-chain of T-cell receptor associated protein kinase 70 (<italic>ZAP70</italic>; degree=11).</p>
</sec>
<sec>
<title>Functional annotation</title>
<p>The enrichment analysis indicated that genes in the PPI network were significantly associated with numerous GO BP terms, including the &#x2018;transmembrane receptor protein tyrosine kinase signaling pathway&#x2019; and &#x2018;peptidyl-tyrosine autophosphorylation&#x2019; (<xref rid="tIII-mmr-18-03-2789" ref-type="table">Table III</xref>). With regard to KEGG pathways, there were five significant pathways, including &#x2018;metabolic pathways&#x2019;, &#x2018;natural killer cell mediated cytotoxicity&#x2019;, &#x2018;fructose and mannose metabolism&#x2019;, &#x2018;primary immunodeficiency&#x2019;, and &#x2018;Fc gamma R-mediated phagocytosis&#x2019; (<xref rid="tIV-mmr-18-03-2789" ref-type="table">Table IV</xref>). Notably, &#x2018;natural killer cell mediated cytotoxicity&#x2019; and &#x2018;primary immunodeficiency&#x2019; pathways were significantly enriched with <italic>LCK</italic> and <italic>ZAP70</italic>.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>CAD remains a primary public health concern (<xref rid="b32-mmr-18-03-2789" ref-type="bibr">32</xref>). The present study attempted to dissect the underlying pathogenic mechanisms of CAD via a combined analysis of four GEO datasets, which contained CAD samples and healthy control samples. A total of 11 modules were detected in the WGCNA network, five of which were highly preserved across all datasets. Using the metaDE method, 836 common DEGs in the four datasets were identified. Furthermore, a PPI network was constructed with the 177 overlapping genes of the DEGs with significant consistency and the five preserved WGCNA modules. According to degree, the top five genes of the PPI network were <italic>LCK, EHMT2, IMPDH2, PPP4C</italic> and <italic>ZAP70</italic>. Notably, multiple significant pathways for genes in the PPI network were identified, including &#x2018;natural killer cell mediated cytotoxicity&#x2019;, &#x2018;primary immunodeficiency&#x2019;, and &#x2018;Fc gamma R-mediated phagocytosis&#x2019; pathways.</p>
<p>The LCK protein encoded by the gene <italic>LCK</italic>, additionally termed lymphocyte-specific protein tyrosine kinase, is a member of the Src family of tyrosine kinases, which are involved in T cell signaling (<xref rid="b33-mmr-18-03-2789" ref-type="bibr">33</xref>). Insufficient deactivation of LCK has been demonstrated to render patients with acute coronary syndrome (ACS) vulnerable to abnormal T cell responses (<xref rid="b34-mmr-18-03-2789" ref-type="bibr">34</xref>). The <italic>ZAP-70</italic> gene encodes the ZAP-70 enzyme, which belongs to the protein-tyrosine kinase family and is a T cell receptor. In T cell signaling, ZAP-70 binds to the CD3 complex that is phosphorylated by the LCK protein (<xref rid="b35-mmr-18-03-2789" ref-type="bibr">35</xref>). It has been established that the ZAP-70 protein expression is able to act as a marker for chronic lymphocytic leukemia or small lymphocytic lymphoma (<xref rid="b36-mmr-18-03-2789" ref-type="bibr">36</xref>).</p>
<p>In the present study, <italic>LCK</italic> (degree=15) and <italic>ZAP70</italic> (degree=11) were highlighted in the PPI network. Furthermore, based on the KEGG pathway enrichment analysis, <italic>LCK</italic> and <italic>ZAP70</italic> were significantly associated with &#x2018;natural killer cell mediated cytotoxicity&#x2019; and &#x2018;primary immunodeficiency&#x2019; pathways, which were associated with immune processes. Similarly, there is evidence that dysregulated adaptive immunity serves a causative role in ACS (<xref rid="b37-mmr-18-03-2789" ref-type="bibr">37</xref>). Therefore, it may be inferred that <italic>LCK</italic> and <italic>ZAP70</italic> serve a role in CAD, which may partly be by regulating natural killer cell mediated cytotoxicity and primary immunodeficiency pathways. Additionally, a previous study with a novel knowledge-based approach revealed that the Fc gamma R-mediated phagocytosis pathway is a pathogenic mechanism for CAD (<xref rid="b38-mmr-18-03-2789" ref-type="bibr">38</xref>). Likewise, the present study suggests that &#x2018;Fc gamma R-mediated phagocytosis&#x2019; may have a function in CAD.</p>
<p>EHMT2, encoded by the gene <italic>EHMT2</italic>, termed G9a, is a histone methyltransferase that serves a critical role in epigenetic regulation within the nucleus accumbens (<xref rid="b39-mmr-18-03-2789" ref-type="bibr">39</xref>). Histone methylation has emerged as a crucial epigenetic mechanism for cardiovascular development and homeostasis (<xref rid="b40-mmr-18-03-2789" ref-type="bibr">40</xref>). Papait <italic>et al</italic> (<xref rid="b41-mmr-18-03-2789" ref-type="bibr">41</xref>) demonstrated that EHMT2 orchestrates important epigenetic alterations in cardiomyocyte homeostasis and hypertrophy. Furthermore, EHMT1/2 has been suggested to be a therapeutic target against pathological cardiac hypertrophy (<xref rid="b42-mmr-18-03-2789" ref-type="bibr">42</xref>). These results are in accordance with the present results, which demonstrated that EHMT2 was a predominant gene in the PPI network (degree=14). These collectively suggest a potentially critical role of EHMT2 in CAD.</p>
<p>IMPDH2, encoded by gene <italic>IMPDH2</italic>, termed IMP dehydrogenase 2, acts as a rate-limiting enzyme in guanine nucleotide biosynthesis (<xref rid="b43-mmr-18-03-2789" ref-type="bibr">43</xref>). It has been reported to be involved in a number of cancer types, including primary nasopharyngeal carcinoma (<xref rid="b44-mmr-18-03-2789" ref-type="bibr">44</xref>) and prostate cancer (<xref rid="b45-mmr-18-03-2789" ref-type="bibr">45</xref>). Nonetheless, the role of IMPDH2 in CAD has been poorly defined. The <italic>PPP4C</italic> gene encodes the PP4C protein, which is a member of the type 2 serine/threonine protein phosphatase family (<xref rid="b46-mmr-18-03-2789" ref-type="bibr">46</xref>), and partly regulates the phosphorylation of numerous proteins implicated in cardiac physiology and hypertrophy (<xref rid="b47-mmr-18-03-2789" ref-type="bibr">47</xref>,<xref rid="b48-mmr-18-03-2789" ref-type="bibr">48</xref>). The present study indicated that <italic>IMPDH2</italic> and <italic>PPP4C</italic> may be important genes in CAD.</p>
<p>Although a comprehensive bioinformatics analysis using four datasets was performed, there were a number of limitations. The potentially important genes associated with CAD lacked gene expression and functional validation. Further studies are required with substantial experiments <italic>in vivo</italic> and <italic>in vitro</italic>. Furthermore, the four datasets were not from the same platform, which may cause numerous deviations. Nevertheless, the present study provides novel insight into CAD pathogenesis.</p>
<p>In conclusion, the present study revealed that <italic>LCK, EHMT2, IMPDH2, PPP4C</italic> and <italic>ZAP70</italic> may be proposed as genetic biomarkers for CAD. They may function via the involvement of the &#x2018;natural killer cell mediated cytotoxicity&#x2019;, &#x2018;primary immunodeficiency&#x2019;, and &#x2018;Fc gamma R-mediated phagocytosis pathways&#x2019; in CAD. These results require further validation with substantial experiments.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec>
<title>Funding</title>
<p>No funding was received.</p>
</sec>
<sec>
<title>Availability of data and materials</title>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>SY performed data analyses, wrote the manuscript, conceived and designed the study.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>In the original article of the datasets, the trials were approved by the local institutional review boards of all participating centers and informed consent was obtained from all patients.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-mmr-18-03-2789"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohira</surname><given-names>T</given-names></name><name><surname>Iso</surname><given-names>H</given-names></name></person-group><article-title>Cardiovascular disease epidemiology in Asia: An overview</article-title><source>Circ J</source><volume>77</volume><fpage>1646</fpage><lpage>1652</lpage><year>2013</year><pub-id pub-id-type="doi">10.1253/circj.CJ-13-0702</pub-id><pub-id pub-id-type="pmid">23803294</pub-id></element-citation></ref>
<ref id="b2-mmr-18-03-2789"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayols-Baixeras</surname><given-names>S</given-names></name><name><surname>Llu&#x00ED;s-Ganella</surname><given-names>C</given-names></name><name><surname>Lucas</surname><given-names>G</given-names></name><name><surname>Elosua</surname><given-names>R</given-names></name></person-group><article-title>Pathogenesis of coronary artery disease: Focus on genetic risk factors and identification of genetic variants</article-title><source>Appl Clin Genet</source><volume>7</volume><fpage>15</fpage><lpage>32</lpage><year>2014</year><pub-id pub-id-type="pmid">24520200</pub-id><pub-id pub-id-type="pmcid">3920464</pub-id></element-citation></ref>
<ref id="b3-mmr-18-03-2789"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torpy</surname><given-names>JM</given-names></name><name><surname>Burke</surname><given-names>AE</given-names></name><name><surname>Glass</surname><given-names>RM</given-names></name></person-group><article-title>Coronary heart disease risk factors</article-title><source>JAMA</source><volume>302</volume><fpage>2388</fpage><year>2009</year><pub-id pub-id-type="doi">10.1001/jama.302.21.2388</pub-id><pub-id pub-id-type="pmid">19952328</pub-id></element-citation></ref>
<ref id="b4-mmr-18-03-2789"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>MA</given-names></name><name><surname>Fareed</surname><given-names>MT</given-names></name><name><surname>Argenio</surname><given-names>SL</given-names></name><name><surname>Agunwamba</surname><given-names>AO</given-names></name><name><surname>Hanson</surname><given-names>TR</given-names></name></person-group><article-title>Coronary artery disease</article-title><source>Prim Care</source><volume>40</volume><fpage>1</fpage><lpage>16</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.pop.2012.12.001</pub-id><pub-id pub-id-type="pmid">23402459</pub-id></element-citation></ref>
<ref id="b5-mmr-18-03-2789"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callaway</surname><given-names>JL</given-names></name><name><surname>Shaffer</surname><given-names>LG</given-names></name><name><surname>Chitty</surname><given-names>LS</given-names></name><name><surname>Rosenfeld</surname><given-names>JA</given-names></name><name><surname>Crolla</surname><given-names>JA</given-names></name></person-group><article-title>The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: A review of the literature</article-title><source>Prenat Diagn</source><volume>33</volume><fpage>1119</fpage><lpage>1133</lpage><year>2013</year><pub-id pub-id-type="doi">10.1002/pd.4209</pub-id><pub-id pub-id-type="pmid">23983223</pub-id><pub-id pub-id-type="pmcid">4285999</pub-id></element-citation></ref>
<ref id="b6-mmr-18-03-2789"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abulwerdi</surname><given-names>FA</given-names></name><name><surname>Schneekloth</surname><given-names>JS</given-names><suffix>Jr</suffix></name></person-group><article-title>Microarray-based technologies for the discovery of selective, RNA-binding molecules</article-title><source>Methods</source><volume>103</volume><fpage>188</fpage><lpage>195</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.ymeth.2016.04.022</pub-id><pub-id pub-id-type="pmid">27109057</pub-id></element-citation></ref>
<ref id="b7-mmr-18-03-2789"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>N</given-names></name><name><surname>Han</surname><given-names>G</given-names></name><name><surname>Geng</surname><given-names>Q</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name></person-group><article-title>Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease</article-title><source>PLoS One</source><volume>8</volume><fpage>e80738</fpage><year>2013</year><pub-id pub-id-type="doi">10.1371/journal.pone.0080738</pub-id><pub-id pub-id-type="pmid">24339880</pub-id><pub-id pub-id-type="pmcid">3855151</pub-id></element-citation></ref>
<ref id="b8-mmr-18-03-2789"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Garg</surname><given-names>G</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Mohammad</surname><given-names>F</given-names></name><name><surname>Kumar</surname><given-names>SR</given-names></name><name><surname>Tanwar</surname><given-names>VS</given-names></name><name><surname>Sati</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Karthikeyan</surname><given-names>G</given-names></name><name><surname>Brahmachari</surname><given-names>V</given-names></name><name><surname>Sengupta</surname><given-names>S</given-names></name></person-group><article-title>Genome wide DNA methylation profiling for epigenetic alteration in coronary artery disease patients</article-title><source>Gene</source><volume>541</volume><fpage>31</fpage><lpage>40</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.gene.2014.02.034</pub-id><pub-id pub-id-type="pmid">24582973</pub-id></element-citation></ref>
<ref id="b9-mmr-18-03-2789"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Jing</surname><given-names>L</given-names></name><name><surname>Tu</surname><given-names>X</given-names></name></person-group><article-title>Weighted gene co-expression network analysis identifies specific modules and hub genes related to coronary artery disease</article-title><source>BMC Cardiovasc Disord</source><volume>16</volume><fpage>54</fpage><year>2016</year><pub-id pub-id-type="doi">10.1186/s12872-016-0217-3</pub-id><pub-id pub-id-type="pmid">26944061</pub-id><pub-id pub-id-type="pmcid">4779223</pub-id></element-citation></ref>
<ref id="b10-mmr-18-03-2789"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Kang</surname><given-names>DD</given-names></name><name><surname>Shen</surname><given-names>K</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Chang</surname><given-names>LC</given-names></name><name><surname>Liao</surname><given-names>SG</given-names></name><name><surname>Huo</surname><given-names>Z</given-names></name><name><surname>Tang</surname><given-names>S</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><etal/></person-group><article-title>An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection</article-title><source>Bioinformatics</source><volume>28</volume><fpage>2534</fpage><lpage>2536</lpage><year>2012</year><pub-id pub-id-type="doi">10.1093/bioinformatics/bts485</pub-id><pub-id pub-id-type="pmid">22863766</pub-id><pub-id pub-id-type="pmcid">3463115</pub-id></element-citation></ref>
<ref id="b11-mmr-18-03-2789"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Han</surname><given-names>T</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name></person-group><article-title>Integrated miRNA-risk gene-pathway pair network analysis provides prognostic biomarkers for gastric cancer</article-title><source>Onco Targets Ther</source><volume>9</volume><fpage>2975</fpage><lpage>2986</lpage><year>2016</year><pub-id pub-id-type="pmid">27284247</pub-id><pub-id pub-id-type="pmcid">4881735</pub-id></element-citation></ref>
<ref id="b12-mmr-18-03-2789"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>C</given-names></name><name><surname>Hong</surname><given-names>L</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Yin</surname><given-names>Q</given-names></name></person-group><article-title>Identification of metastasis-associated genes in colorectal cancer using metaDE and survival analysis</article-title><source>Oncol Lett</source><volume>11</volume><fpage>568</fpage><lpage>574</lpage><year>2016</year><pub-id pub-id-type="doi">10.3892/ol.2015.3956</pub-id><pub-id pub-id-type="pmid">26870249</pub-id></element-citation></ref>
<ref id="b13-mmr-18-03-2789"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinnaeve</surname><given-names>PR</given-names></name><name><surname>Donahue</surname><given-names>MP</given-names></name><name><surname>Grass</surname><given-names>P</given-names></name><name><surname>Seo</surname><given-names>D</given-names></name><name><surname>Vonderscher</surname><given-names>J</given-names></name><name><surname>Chibout</surname><given-names>SD</given-names></name><name><surname>Kraus</surname><given-names>WE</given-names></name><name><surname>Sketch</surname><given-names>M</given-names><suffix>Jr</suffix></name><name><surname>Nelson</surname><given-names>C</given-names></name><name><surname>Ginsburg</surname><given-names>GS</given-names></name><etal/></person-group><article-title>Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease</article-title><source>PLoS One</source><volume>4</volume><fpage>e7037</fpage><year>2009</year><pub-id pub-id-type="doi">10.1371/journal.pone.0007037</pub-id><pub-id pub-id-type="pmid">19750006</pub-id><pub-id pub-id-type="pmcid">2736586</pub-id></element-citation></ref>
<ref id="b14-mmr-18-03-2789"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elashoff</surname><given-names>MR</given-names></name><name><surname>Wingrove</surname><given-names>JA</given-names></name><name><surname>Beineke</surname><given-names>P</given-names></name><name><surname>Daniels</surname><given-names>SE</given-names></name><name><surname>Tingley</surname><given-names>WG</given-names></name><name><surname>Rosenberg</surname><given-names>S</given-names></name><name><surname>Voros</surname><given-names>S</given-names></name><name><surname>Kraus</surname><given-names>WE</given-names></name><name><surname>Ginsburg</surname><given-names>GS</given-names></name><name><surname>Schwartz</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients</article-title><source>BMC Med Genomics</source><volume>4</volume><fpage>26</fpage><year>2011</year><pub-id pub-id-type="doi">10.1186/1755-8794-4-26</pub-id><pub-id pub-id-type="pmid">21443790</pub-id><pub-id pub-id-type="pmcid">3072303</pub-id></element-citation></ref>
<ref id="b15-mmr-18-03-2789"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beineke</surname><given-names>P</given-names></name><name><surname>Fitch</surname><given-names>K</given-names></name><name><surname>Tao</surname><given-names>H</given-names></name><name><surname>Elashoff</surname><given-names>MR</given-names></name><name><surname>Rosenberg</surname><given-names>S</given-names></name><name><surname>Kraus</surname><given-names>WE</given-names></name><name><surname>Wingrove</surname><given-names>JA</given-names></name></person-group><article-title>PREDICT Investigators: A whole blood gene expression-based signature for smoking status</article-title><source>BMC Med Genomics</source><volume>5</volume><fpage>58</fpage><year>2012</year><pub-id pub-id-type="doi">10.1186/1755-8794-5-58</pub-id><pub-id pub-id-type="pmid">23210427</pub-id><pub-id pub-id-type="pmcid">3538056</pub-id></element-citation></ref>
<ref id="b16-mmr-18-03-2789"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parrish</surname><given-names>RS</given-names></name><name><surname>Spencer</surname><given-names>HJ</given-names><suffix>III</suffix></name></person-group><article-title>Effect of normalization on significance testing for oligonucleotide microarrays</article-title><source>J Biopharm Stat</source><volume>14</volume><fpage>575</fpage><lpage>589</lpage><year>2004</year><pub-id pub-id-type="doi">10.1081/BIP-200025650</pub-id><pub-id pub-id-type="pmid">15468753</pub-id></element-citation></ref>
<ref id="b17-mmr-18-03-2789"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>ME</given-names></name><name><surname>Phipson</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Law</surname><given-names>CW</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>Limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title><source>Nucleic Acids Res</source><volume>43</volume><fpage>e47</fpage><year>2015</year><pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id><pub-id pub-id-type="pmid">25605792</pub-id><pub-id pub-id-type="pmcid">4402510</pub-id></element-citation></ref>
<ref id="b18-mmr-18-03-2789"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname><given-names>P</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><article-title>WGCNA: An R package for weighted correlation network analysis</article-title><source>BMC Bioinformatics</source><volume>9</volume><fpage>559</fpage><year>2008</year><pub-id pub-id-type="doi">10.1186/1471-2105-9-559</pub-id><pub-id pub-id-type="pmid">19114008</pub-id><pub-id pub-id-type="pmcid">2631488</pub-id></element-citation></ref>
<ref id="b19-mmr-18-03-2789"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><article-title>A general framework for weighted gene co-expression network analysis</article-title><source>Stat Appl Genet Mol Biol</source><volume>4</volume><comment>Article17</comment><year>2005</year><pub-id pub-id-type="doi">10.2202/1544-6115.1128</pub-id><pub-id pub-id-type="pmid">16646834</pub-id></element-citation></ref>
<ref id="b20-mmr-18-03-2789"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>X</given-names></name><name><surname>Xue</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name></person-group><article-title>Colon cancer recurrence-associated genes revealed by WGCNA co-expression network analysis</article-title><source>Mol Med Rep</source><volume>16</volume><fpage>6499</fpage><lpage>6505</lpage><year>2017</year><pub-id pub-id-type="doi">10.3892/mmr.2017.7412</pub-id><pub-id pub-id-type="pmid">28901407</pub-id><pub-id pub-id-type="pmcid">5865817</pub-id></element-citation></ref>
<ref id="b21-mmr-18-03-2789"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilne</surname><given-names>B</given-names></name><name><surname>Skogsberg</surname><given-names>J</given-names></name><name><surname>Asl</surname><given-names>Foroughi H</given-names></name><name><surname>Talukdar</surname><given-names>HA</given-names></name><name><surname>Kessler</surname><given-names>T</given-names></name><name><surname>Bj&#x00F6;rkegren</surname><given-names>JLM</given-names></name><name><surname>Schunkert</surname><given-names>H</given-names></name></person-group><article-title>Network analysis reveals a causal role of mitochondrial gene activity in atherosclerotic lesion formation</article-title><source>Atherosclerosis</source><volume>267</volume><fpage>39</fpage><lpage>48</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2017.10.019</pub-id><pub-id pub-id-type="pmid">29100060</pub-id></element-citation></ref>
<ref id="b22-mmr-18-03-2789"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Xiong</surname><given-names>B</given-names></name></person-group><article-title>Identification of two novel biomarkers of rectal carcinoma progression and prognosis via co-expression network analysis</article-title><source>Oncotarget</source><volume>8</volume><fpage>69594</fpage><lpage>69609</lpage><year>2017</year><pub-id pub-id-type="pmid">29050227</pub-id><pub-id pub-id-type="pmcid">5642502</pub-id></element-citation></ref>
<ref id="b23-mmr-18-03-2789"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yip</surname><given-names>AM</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><article-title>Gene network interconnectedness and the generalized topological overlap measure</article-title><source>BMC Bioinformatics</source><volume>8</volume><fpage>22</fpage><year>2007</year><pub-id pub-id-type="doi">10.1186/1471-2105-8-22</pub-id><pub-id pub-id-type="pmid">17250769</pub-id><pub-id pub-id-type="pmcid">1797055</pub-id></element-citation></ref>
<ref id="b24-mmr-18-03-2789"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Jang</surname><given-names>X</given-names></name></person-group><article-title>Identification of potentially critical differentially methylated genes in nasopharyngeal carcinoma: A comprehensive analysis of methylation profiling and gene expression profiling</article-title><source>Oncol Lett</source><volume>14</volume><fpage>7171</fpage><lpage>7178</lpage><year>2017</year><pub-id pub-id-type="pmid">29344148</pub-id><pub-id pub-id-type="pmcid">5754830</pub-id></element-citation></ref>
<ref id="b25-mmr-18-03-2789"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatraryamontri</surname><given-names>A</given-names></name><name><surname>Breitkreutz</surname><given-names>BJ</given-names></name><name><surname>Oughtred</surname><given-names>R</given-names></name><name><surname>Boucher</surname><given-names>L</given-names></name><name><surname>Heinicke</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Stark</surname><given-names>C</given-names></name><name><surname>Breitkreutz</surname><given-names>A</given-names></name><name><surname>Kolas</surname><given-names>N</given-names></name><name><surname>O&#x0027;Donnell</surname><given-names>L</given-names></name><etal/></person-group><article-title>The BioGRID interaction database: 2015 update</article-title><source>Nucleic Acids Res</source><volume>43</volume><comment>(Database Issue)</comment><fpage>D470</fpage><lpage>D478</lpage><year>2015</year><pub-id pub-id-type="doi">10.1093/nar/gku1204</pub-id><pub-id pub-id-type="pmid">25428363</pub-id></element-citation></ref>
<ref id="b26-mmr-18-03-2789"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>Keshava TS</given-names></name><name><surname>Goel</surname><given-names>R</given-names></name><name><surname>Kandasamy</surname><given-names>K</given-names></name><name><surname>Keerthikumar</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Mathivanan</surname><given-names>S</given-names></name><name><surname>Telikicherla</surname><given-names>D</given-names></name><name><surname>Raju</surname><given-names>R</given-names></name><name><surname>Shafreen</surname><given-names>B</given-names></name><name><surname>Venugopal</surname><given-names>A</given-names></name><etal/></person-group><article-title>Human protein reference database-2009 update</article-title><source>Nucleic Acids Res</source><volume>37</volume><comment>(Database Issue)</comment><fpage>D767</fpage><lpage>D772</lpage><year>2009</year><pub-id pub-id-type="doi">10.1093/nar/gkn892</pub-id><pub-id pub-id-type="pmid">18988627</pub-id></element-citation></ref>
<ref id="b27-mmr-18-03-2789"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szklarczyk</surname><given-names>D</given-names></name><name><surname>Franceschini</surname><given-names>A</given-names></name><name><surname>Kuhn</surname><given-names>M</given-names></name><name><surname>Simonovic</surname><given-names>M</given-names></name><name><surname>Roth</surname><given-names>A</given-names></name><name><surname>Minguez</surname><given-names>P</given-names></name><name><surname>Doerks</surname><given-names>T</given-names></name><name><surname>Stark</surname><given-names>M</given-names></name><name><surname>Muller</surname><given-names>J</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><etal/></person-group><article-title>The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored</article-title><source>Nucleic Acids Res</source><volume>39</volume><comment>(Database Issue)</comment><fpage>D561</fpage><lpage>D568</lpage><year>2011</year><pub-id pub-id-type="doi">10.1093/nar/gkq973</pub-id><pub-id pub-id-type="pmid">21045058</pub-id></element-citation></ref>
<ref id="b28-mmr-18-03-2789"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>CT</given-names></name><name><surname>Franz</surname><given-names>M</given-names></name><name><surname>Kazi</surname><given-names>F</given-names></name><name><surname>Donaldson</surname><given-names>SL</given-names></name><name><surname>Morris</surname><given-names>Q</given-names></name><name><surname>Bader</surname><given-names>GD</given-names></name></person-group><article-title>Cytoscape Web: An interactive web-based network browser</article-title><source>Bioinformatics</source><volume>26</volume><fpage>2347</fpage><lpage>2348</lpage><year>2010</year><pub-id pub-id-type="doi">10.1093/bioinformatics/btq430</pub-id><pub-id pub-id-type="pmid">20656902</pub-id><pub-id pub-id-type="pmcid">2935447</pub-id></element-citation></ref>
<ref id="b29-mmr-18-03-2789"><label>29</label><element-citation publication-type="journal"><article-title>Gene Ontology Consortium: Gene ontology consortium: Going forward</article-title><source>Nucleic Acids Res</source><volume>43</volume><comment>(Database Issue)</comment><fpage>D1049</fpage><lpage>D1056</lpage><year>2015</year><pub-id pub-id-type="doi">10.1093/nar/gku1179</pub-id><pub-id pub-id-type="pmid">25428369</pub-id></element-citation></ref>
<ref id="b30-mmr-18-03-2789"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Kawashima</surname><given-names>M</given-names></name><name><surname>Furumichi</surname><given-names>M</given-names></name><name><surname>Tanabe</surname><given-names>M</given-names></name></person-group><article-title>KEGG as a reference resource for gene and protein annotation</article-title><source>Nucleic Acids Res</source><volume>44</volume><issue>D1</issue><fpage>D457</fpage><lpage>D462</lpage><year>2016</year><pub-id pub-id-type="doi">10.1093/nar/gkv1070</pub-id><pub-id pub-id-type="pmid">26476454</pub-id></element-citation></ref>
<ref id="b31-mmr-18-03-2789"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Huang</surname><given-names>W</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title><source>Nat Protoc</source><volume>4</volume><fpage>44</fpage><lpage>57</lpage><year>2009</year><pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><pub-id pub-id-type="pmid">19131956</pub-id></element-citation></ref>
<ref id="b32-mmr-18-03-2789"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>MA</given-names></name><name><surname>Fareed</surname><given-names>MT</given-names></name><name><surname>Argenio</surname><given-names>SL</given-names></name><name><surname>Agunwamba</surname><given-names>AO</given-names></name><name><surname>Hanson</surname><given-names>TR</given-names></name></person-group><article-title>Coronary artery disease</article-title><source>Prim Care</source><volume>40</volume><fpage>1</fpage><lpage>16</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.pop.2012.12.001</pub-id><pub-id pub-id-type="pmid">23402459</pub-id></element-citation></ref>
<ref id="b33-mmr-18-03-2789"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname><given-names>DP</given-names></name><name><surname>Kundu</surname><given-names>GC</given-names></name></person-group><article-title>LCK (lymphocyte-specific protein tyrosine kinase)</article-title><source>Atlas Genet Cytogenet Oncol Haematol</source><volume>9</volume><fpage>229</fpage><lpage>230</lpage><year>2005</year></element-citation></ref>
<ref id="b34-mmr-18-03-2789"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryshchep</surname><given-names>S</given-names></name><name><surname>Goronzy</surname><given-names>JJ</given-names></name><name><surname>Parashar</surname><given-names>S</given-names></name><name><surname>Weyand</surname><given-names>CM</given-names></name></person-group><article-title>Insufficient deactivation of the protein tyrosine kinase lck amplifies T-cell responsiveness in acute coronary syndrome</article-title><source>Circ Res</source><volume>106</volume><fpage>769</fpage><lpage>778</lpage><year>2010</year><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.206052</pub-id><pub-id pub-id-type="pmid">20035083</pub-id></element-citation></ref>
<ref id="b35-mmr-18-03-2789"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelosi</surname><given-names>M</given-names></name><name><surname>Di Bartolo</surname><given-names>V</given-names></name><name><surname>Mounier</surname><given-names>V</given-names></name><name><surname>M&#x00E8;ge</surname><given-names>D</given-names></name><name><surname>Pascussi</surname><given-names>JM</given-names></name><name><surname>Dufour</surname><given-names>E</given-names></name><name><surname>Blondel</surname><given-names>A</given-names></name><name><surname>Acuto</surname><given-names>O</given-names></name></person-group><article-title>Tyrosine 319 in the interdomain B of ZAP-70 is a binding site for the Src homology 2 domain of Lck</article-title><source>J Biol Chem</source><volume>274</volume><fpage>14229</fpage><lpage>14237</lpage><year>1999</year><pub-id pub-id-type="doi">10.1074/jbc.274.20.14229</pub-id><pub-id pub-id-type="pmid">10318843</pub-id></element-citation></ref>
<ref id="b36-mmr-18-03-2789"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staudt</surname><given-names>LM</given-names></name><name><surname>Rosenwald</surname><given-names>A</given-names></name><name><surname>Wilson</surname><given-names>W</given-names></name><name><surname>Barry</surname><given-names>TS</given-names></name><name><surname>Wiestner</surname><given-names>A</given-names></name></person-group><article-title>ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)</article-title><source>US Patent 7,981,610 B2</source><comment>Filed December 12, 2007; issued July 19</comment><year>2011</year></element-citation></ref>
<ref id="b37-mmr-18-03-2789"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flego</surname><given-names>D</given-names></name><name><surname>Liuzzo</surname><given-names>G</given-names></name><name><surname>Weyand</surname><given-names>CM</given-names></name><name><surname>Crea</surname><given-names>F</given-names></name></person-group><article-title>Adaptive immunity dysregulation in acute coronary syndromes: From cellular and molecular basis to clinical implications</article-title><source>J Am Coll Cardiol</source><volume>68</volume><fpage>2107</fpage><lpage>2117</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.jacc.2016.08.036</pub-id><pub-id pub-id-type="pmid">27810051</pub-id><pub-id pub-id-type="pmcid">5651170</pub-id></element-citation></ref>
<ref id="b38-mmr-18-03-2789"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zuo</surname><given-names>X</given-names></name><name><surname>Ouyang</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Zhong</surname><given-names>S</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name></person-group><article-title>Identifying functional modules for coronary artery disease by a prior knowledge-based approach</article-title><source>Gene</source><volume>537</volume><fpage>260</fpage><lpage>268</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.gene.2013.12.049</pub-id><pub-id pub-id-type="pmid">24389497</pub-id></element-citation></ref>
<ref id="b39-mmr-18-03-2789"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tachibana</surname><given-names>M</given-names></name><name><surname>Sugimoto</surname><given-names>K</given-names></name><name><surname>Fukushima</surname><given-names>T</given-names></name><name><surname>Shinkai</surname><given-names>Y</given-names></name></person-group><article-title>Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity nd specific selectivity to lysines 9 and 27 of histone H3</article-title><source>J Biol Chem</source><volume>276</volume><fpage>25309</fpage><lpage>25317</lpage><year>2001</year><pub-id pub-id-type="doi">10.1074/jbc.M101914200</pub-id><pub-id pub-id-type="pmid">11316813</pub-id></element-citation></ref>
<ref id="b40-mmr-18-03-2789"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>QJ</given-names></name><name><surname>Liu</surname><given-names>ZP</given-names></name></person-group><article-title>Histone methylations in heart development, congenital and adult heart diseases</article-title><source>Epigenomics</source><volume>7</volume><fpage>321</fpage><lpage>330</lpage><year>2015</year><pub-id pub-id-type="doi">10.2217/epi.14.60</pub-id><pub-id pub-id-type="pmid">25942538</pub-id><pub-id pub-id-type="pmcid">4451103</pub-id></element-citation></ref>
<ref id="b41-mmr-18-03-2789"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papait</surname><given-names>R</given-names></name><name><surname>Serio</surname><given-names>S</given-names></name><name><surname>Pagiatakis</surname><given-names>C</given-names></name><name><surname>Rusconi</surname><given-names>F</given-names></name><name><surname>Carullo</surname><given-names>P</given-names></name><name><surname>Mazzola</surname><given-names>M</given-names></name><name><surname>Salvarani</surname><given-names>N</given-names></name><name><surname>Miragoli</surname><given-names>M</given-names></name><name><surname>Condorelli</surname><given-names>G</given-names></name></person-group><article-title>Histone methyltransferase G9a is required for cardiomyocyte homeostasis and hypertrophy</article-title><source>Circulation</source><volume>136</volume><fpage>1233</fpage><lpage>1246</lpage><year>2017</year><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.117.028561</pub-id><pub-id pub-id-type="pmid">28778944</pub-id></element-citation></ref>
<ref id="b42-mmr-18-03-2789"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thienpont</surname><given-names>B</given-names></name><name><surname>Aronsen</surname><given-names>JM</given-names></name><name><surname>Robinson</surname><given-names>EL</given-names></name><name><surname>Okkenhaug</surname><given-names>H</given-names></name><name><surname>Loche</surname><given-names>E</given-names></name><name><surname>Ferrini</surname><given-names>A</given-names></name><name><surname>Brien</surname><given-names>P</given-names></name><name><surname>Alkass</surname><given-names>K</given-names></name><name><surname>Tomasso</surname><given-names>A</given-names></name><name><surname>Agrawal</surname><given-names>A</given-names></name><etal/></person-group><article-title>The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy</article-title><source>J Clin Invest</source><volume>127</volume><fpage>335</fpage><lpage>348</lpage><year>2017</year><pub-id pub-id-type="doi">10.1172/JCI88353</pub-id><pub-id pub-id-type="pmid">27893464</pub-id></element-citation></ref>
<ref id="b43-mmr-18-03-2789"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bremer</surname><given-names>S</given-names></name><name><surname>Rootwelt</surname><given-names>H</given-names></name><name><surname>Bergan</surname><given-names>S</given-names></name></person-group><article-title>Real-time PCR determination of IMPDH1 and IMPDH2 expression in blood cells</article-title><source>Clin Chem</source><volume>53</volume><fpage>1023</fpage><lpage>1029</lpage><year>2007</year><pub-id pub-id-type="doi">10.1373/clinchem.2006.081968</pub-id><pub-id pub-id-type="pmid">17463174</pub-id></element-citation></ref>
<ref id="b44-mmr-18-03-2789"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Rong</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Yun</surname><given-names>M</given-names></name><name><surname>Weng</surname><given-names>H</given-names></name><name><surname>Ye</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma</article-title><source>Sci Rep</source><volume>7</volume><fpage>745</fpage><year>2017</year><pub-id pub-id-type="doi">10.1038/s41598-017-00887-1</pub-id><pub-id pub-id-type="pmid">28389646</pub-id><pub-id pub-id-type="pmcid">5429725</pub-id></element-citation></ref>
<ref id="b45-mmr-18-03-2789"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Xia</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Mo</surname><given-names>R</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Dai</surname><given-names>Q</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer</article-title><source>Clin Transl Oncol</source><volume>16</volume><fpage>906</fpage><lpage>913</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s12094-014-1167-9</pub-id><pub-id pub-id-type="pmid">24659377</pub-id></element-citation></ref>
<ref id="b46-mmr-18-03-2789"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gingras</surname><given-names>AC</given-names></name><name><surname>Caballero</surname><given-names>M</given-names></name><name><surname>Zarske</surname><given-names>M</given-names></name><name><surname>Sanchez</surname><given-names>A</given-names></name><name><surname>Hazbun</surname><given-names>TR</given-names></name><name><surname>Fields</surname><given-names>S</given-names></name><name><surname>Sonenberg</surname><given-names>N</given-names></name><name><surname>Hafen</surname><given-names>E</given-names></name><name><surname>Raught</surname><given-names>B</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name></person-group><article-title>A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity</article-title><source>Mol Cell Proteomics</source><volume>4</volume><fpage>1725</fpage><lpage>1740</lpage><year>2005</year><pub-id pub-id-type="doi">10.1074/mcp.M500231-MCP200</pub-id><pub-id pub-id-type="pmid">16085932</pub-id></element-citation></ref>
<ref id="b47-mmr-18-03-2789"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eleftheriadou</surname><given-names>O</given-names></name><name><surname>Longman</surname><given-names>MR</given-names></name><name><surname>Boguslavskyi</surname><given-names>A</given-names></name><name><surname>Ryan</surname><given-names>A</given-names></name><name><surname>Wadzinski</surname><given-names>BE</given-names></name><name><surname>Shattock</surname><given-names>MJ</given-names></name><name><surname>Snabaitis</surname><given-names>AK</given-names></name></person-group><article-title>Expression of type 2a protein phosphatases in cardiac health and disease</article-title><source>Heart</source><volume>100</volume><fpage>A16</fpage><year>2014</year><pub-id pub-id-type="doi">10.1136/heartjnl-2014-306916.49</pub-id></element-citation></ref>
<ref id="b48-mmr-18-03-2789"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eleftheriadou</surname><given-names>O</given-names></name><name><surname>Boguslavskyi</surname><given-names>A</given-names></name><name><surname>Longman</surname><given-names>MR</given-names></name><name><surname>Cowan</surname><given-names>J</given-names></name><name><surname>Francois</surname><given-names>A</given-names></name><name><surname>Heads</surname><given-names>RJ</given-names></name><name><surname>Wadzinski</surname><given-names>BE</given-names></name><name><surname>Ryan</surname><given-names>A</given-names></name><name><surname>Shattock</surname><given-names>MJ</given-names></name><name><surname>Snabaitis</surname><given-names>AK</given-names></name></person-group><article-title>Expression and regulation of type 2A protein phosphatases and alpha4 signalling in cardiac health and hypertrophy</article-title><source>Basic Res Cardiol</source><volume>112</volume><fpage>37</fpage><year>2017</year><pub-id pub-id-type="doi">10.1007/s00395-017-0625-2</pub-id><pub-id pub-id-type="pmid">28526910</pub-id><pub-id pub-id-type="pmcid">5438423</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-18-03-2789" position="float">
<label>Figure 1.</label>
<caption><p>Correlation analysis of genes in four datasets from the Gene Expression Omnibus database. CC, correlation coefficient.</p></caption>
<graphic xlink:href="MMR-18-03-2789-g00.tif"/>
</fig>
<fig id="f2-mmr-18-03-2789" position="float">
<label>Figure 2.</label>
<caption><p>Identification of gene co-expression modules. (A) Training set GSE12288, and three validation sets, (B) GSE20680, (C) GSE20681 and (D) GSE42148, were examined. Modules are marked in different colors.</p></caption>
<graphic xlink:href="MMR-18-03-2789-g01.tif"/>
</fig>
<fig id="f3-mmr-18-03-2789" position="float">
<label>Figure 3.</label>
<caption><p>MDS plot and hierarchical dendrograms of the four datasets. (A) MDS plot of expression data of genes in 11 modules. (B) Hierarchical clustering tree of 11 modules in the four datasets. Modules are denoted via a &#x2018;D&#x2019; and &#x2018;M&#x2019; system: D1, GSE12288; D2, GSE20681; D3, GSE20680; D4, GSE42148; M1, black; M2, dark blue; M3, brown; M4, green; M5, grey; M6, magenta; M7, red; M8, pink; M9, turquoise; M10, yellow; and M11, purple. MDS, multi-dimensional scaling.</p></caption>
<graphic xlink:href="MMR-18-03-2789-g02.tif"/>
</fig>
<fig id="f4-mmr-18-03-2789" position="float">
<label>Figure 4.</label>
<caption><p>Heatmap of hierarchical clustering of differentially expressed genes with significant consistency, identified using the metaDE method. CAD and normal samples notably differed from each other with respect to gene expression patterns. CAD, coronary artery disease.</p></caption>
<graphic xlink:href="MMR-18-03-2789-g03.tiff"/>
</fig>
<fig id="f5-mmr-18-03-2789" position="float">
<label>Figure 5.</label>
<caption><p>Analysis of overlapping genes. (A) Venn diagram of the overlapping genes between WGCNA modules (green) and the genes with significant consistency identified using MetaDE (pink). (B) Numbers of overlapping genes in each of the five highly preserved WGCNA modules. WGCNA, weighted gene co-expression network.</p></caption>
<graphic xlink:href="MMR-18-03-2789-g04.tif"/>
</fig>
<fig id="f6-mmr-18-03-2789" position="float">
<label>Figure 6.</label>
<caption><p>Construction of the PPI network. (A) Venn diagram of PPIs obtained from BioGRID, HPRD Release 9 and STRING. (B) PPI network. A red triangle denotes an upregulated gene and a green inverted triangle denotes a downregulated gene. The top five genes with higher degrees compared with the other genes in the network are represented by five extra-large green inverted triangles, separately. PPI, protein-protein interaction; BioGRID, Biological General Repository for Interaction Datasets; HPRD, Human Protein Reference Database; LCK, LCK proto-oncogene, Src family tyrosine kinase; EHMT2, euchromatic histone lysine methyltransferase 2; IMPDH2, inosine monophosphate dehydrogenase 2; PPP4C, protein phosphatase 4 catalytic subunit; ZAP70, &#x03B6;-chain of T-cell receptor associated protein kinase 70.</p></caption>
<graphic xlink:href="MMR-18-03-2789-g05.tif"/>
</fig>
<table-wrap id="tI-mmr-18-03-2789" position="float">
<label>Table I.</label>
<caption><p>Information on the four Gene Expression Omnibus datasets.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Accession no.</th>
<th align="center" valign="bottom">Platform</th>
<th align="center" valign="bottom">Probe no.</th>
<th align="center" valign="bottom">Total sample no.</th>
<th align="center" valign="bottom">CAD</th>
<th align="center" valign="bottom">Control</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">GSE12288</td>
<td align="left" valign="top">GPL96</td>
<td align="center" valign="top">22283</td>
<td align="center" valign="top">222</td>
<td align="center" valign="top">112</td>
<td align="center" valign="top">110</td>
</tr>
<tr>
<td align="left" valign="top">GSE20680</td>
<td align="left" valign="top">GPL4133</td>
<td align="center" valign="top">45220</td>
<td align="center" valign="top">139</td>
<td align="center" valign="top">87</td>
<td align="center" valign="top">52</td>
</tr>
<tr>
<td align="left" valign="top">GSE20681</td>
<td align="left" valign="top">GPL4133</td>
<td align="center" valign="top">45220</td>
<td align="center" valign="top">198</td>
<td align="center" valign="top">99</td>
<td align="center" valign="top">99</td>
</tr>
<tr>
<td align="left" valign="top">GSE42148</td>
<td align="left" valign="top">GPL13607</td>
<td align="center" valign="top">62976</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">11</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-mmr-18-03-2789"><p>CAD, coronary artery disease.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-mmr-18-03-2789" position="float">
<label>Table II.</label>
<caption><p>Characteristics of weighted gene co-expression network modules.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" valign="bottom" colspan="4">Dataset</th>
<th align="center" valign="bottom" colspan="4">Characteristic</th>
</tr>
<tr>
<th align="center" valign="bottom" colspan="4"><hr/></th>
<th align="center" valign="bottom" colspan="4"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">GSE12288</th>
<th align="center" valign="bottom">GSE20681</th>
<th align="center" valign="bottom">GSE20680</th>
<th align="center" valign="bottom">GSE42148</th>
<th align="center" valign="bottom">Color</th>
<th align="center" valign="bottom">Size</th>
<th align="center" valign="bottom">Z-score</th>
<th align="center" valign="bottom">Module characterization</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">D1M1</td>
<td align="left" valign="top">D2M1</td>
<td align="left" valign="top">D3M1</td>
<td align="left" valign="top">D4M1</td>
<td align="left" valign="top">Black</td>
<td align="center" valign="top">85</td>
<td align="center" valign="top">13.81</td>
<td align="left" valign="top">Response to glucocorticoid stimulus</td>
</tr>
<tr>
<td align="left" valign="top">D1M2</td>
<td align="left" valign="top">D2M2</td>
<td align="left" valign="top">D3M2</td>
<td align="left" valign="top">D4M2</td>
<td align="left" valign="top">Blue</td>
<td align="center" valign="top">285</td>
<td align="center" valign="top">0.58</td>
<td align="left" valign="top">Humoral immune response</td>
</tr>
<tr>
<td align="left" valign="top">D1M3</td>
<td align="left" valign="top">D2M3</td>
<td align="left" valign="top">D3M3</td>
<td align="left" valign="top">D4M3</td>
<td align="left" valign="top">Brown</td>
<td align="center" valign="top">211</td>
<td align="center" valign="top">5.26</td>
<td align="left" valign="top">Regulation of transcription</td>
</tr>
<tr>
<td align="left" valign="top">D1M4</td>
<td align="left" valign="top">D2M4</td>
<td align="left" valign="top">D3M4</td>
<td align="left" valign="top">D4M4</td>
<td align="left" valign="top">Green</td>
<td align="center" valign="top">121</td>
<td align="center" valign="top">0.16</td>
<td align="left" valign="top">Regulation of transcription</td>
</tr>
<tr>
<td align="left" valign="top">D1M5</td>
<td align="left" valign="top">D2M5</td>
<td align="left" valign="top">D3M5</td>
<td align="left" valign="top">D4M5</td>
<td align="left" valign="top">Grey</td>
<td align="center" valign="top">572</td>
<td align="center" valign="top">3.92</td>
<td align="left" valign="top">Defense response</td>
</tr>
<tr>
<td align="left" valign="top">D1M6</td>
<td align="left" valign="top">D2M6</td>
<td align="left" valign="top">D3M6</td>
<td align="left" valign="top">D4M6</td>
<td align="left" valign="top">Magenta</td>
<td align="center" valign="top">51</td>
<td align="center" valign="top">5.66</td>
<td align="left" valign="top">Protein localization</td>
</tr>
<tr>
<td align="left" valign="top">D1M7</td>
<td align="left" valign="top">D2M7</td>
<td align="left" valign="top">D3M7</td>
<td align="left" valign="top">D4M7</td>
<td align="left" valign="top">Red</td>
<td align="center" valign="top">68</td>
<td align="center" valign="top">0.63</td>
<td align="left" valign="top">Cell surface receptor linked signal transduction</td>
</tr>
<tr>
<td align="left" valign="top">D1M8</td>
<td align="left" valign="top">D2M8</td>
<td align="left" valign="top">D3M8</td>
<td align="left" valign="top">D4M8</td>
<td align="left" valign="top">Pink</td>
<td align="center" valign="top">108</td>
<td align="center" valign="top">1.31</td>
<td align="left" valign="top">Second-messenger-mediated signaling</td>
</tr>
<tr>
<td align="left" valign="top">D1M9</td>
<td align="left" valign="top">D2M9</td>
<td align="left" valign="top">D3M9</td>
<td align="left" valign="top">D4M9</td>
<td align="left" valign="top">Turquoise</td>
<td align="center" valign="top">400</td>
<td align="center" valign="top">14.34</td>
<td align="left" valign="top">Immune response</td>
</tr>
<tr>
<td align="left" valign="top">D1M10</td>
<td align="left" valign="top">D2M10</td>
<td align="left" valign="top">D3M10</td>
<td align="left" valign="top">D4M10</td>
<td align="left" valign="top">Yellow</td>
<td align="center" valign="top">126</td>
<td align="center" valign="top">12.54</td>
<td align="left" valign="top">Immune response</td>
</tr>
<tr>
<td align="left" valign="top">D1M11</td>
<td align="left" valign="top">D2M11</td>
<td align="left" valign="top">D3M11</td>
<td align="left" valign="top">D4M11</td>
<td align="left" valign="top">Purple</td>
<td align="center" valign="top">50</td>
<td align="center" valign="top">1.35</td>
<td align="left" valign="top">Lymphocyte activation</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="tIII-mmr-18-03-2789" position="float">
<label>Table III.</label>
<caption><p>Significant GO terms.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Category</th>
<th align="center" valign="bottom">Term</th>
<th align="center" valign="bottom">Count of genes</th>
<th align="center" valign="bottom">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Biology process</td>
<td align="left" valign="top">Transmembrane receptor protein tyrosine kinase signaling pathway</td>
<td align="center" valign="top">9</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Peptidyl-tyrosine autophosphorylation</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Oxidation-reduction process</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Inflammatory response</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Mesoderm development</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Innate immune response</td>
<td align="center" valign="top">9</td>
<td align="center" valign="top">0.003</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Carbohydrate phosphorylation</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">0.007</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Regulation of defense response to virus by virus</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">0.011</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Chromatin remodeling</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">0.013</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Response to lipopolysaccharide</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">0.014</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Protein autophosphorylation</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">0.017</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Peptidyl-lysine modification to peptidyl-hypusine</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">0.022</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Lymphocyte proliferation</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">0.028</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Fc-gamma receptor signaling pathway involved in phagocytosis</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">0.035</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Response to fungicide</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">0.039</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Negative regulation of B cell activation</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">0.039</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Apoptotic process</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">0.042</td>
</tr>
<tr>
<td align="left" valign="top">Cellular component</td>
<td align="left" valign="top">Extrinsic component of cytoplasmic side of plasma membrane</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">0.000</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Ruffle</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">0.012</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Protein phosphatase 4 complex</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">0.021</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Neuron projection</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">0.038</td>
</tr>
<tr>
<td align="left" valign="top">Molecular function</td>
<td align="left" valign="top">Protein tyrosine kinase activity</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">0.007</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Kinase activity</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">0.013</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Insulin receptor binding</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">0.014</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Electron carrier activity</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">0.015</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Cholestenone 5-alpha-reductase activity</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">0.017</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Catalytic activity</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">0.023</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Poly(A) RNA binding</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">0.028</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Oxidoreductase activity</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">0.028</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">mRNA 3&#x2032;-untranslated region binding</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">0.032</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Receptor activity</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">0.037</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">Enzyme binding</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">0.043</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn2-mmr-18-03-2789"><p>Count of genes represents the number of genes significantly enriched in each GO term. GO, gene ontology.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIV-mmr-18-03-2789" position="float">
<label>Table IV.</label>
<caption><p>Significant KEGG signaling pathways.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Term</th>
<th align="center" valign="bottom">Count</th>
<th align="center" valign="bottom">P-value</th>
<th align="center" valign="bottom">Genes</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Metabolic pathways</td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">0.001</td>
<td align="left" valign="top">GCDH, CES1, GNE, AMACR, SPHK1, PISD, CKB, GCH1, ALDH1A1, ADI1, HK3, NT5C2, AKR1B1, SMPD1, MBOAT2, CDA, CYP4F3, ACSL4, PCYT2, IMPDH2, CBS, AOC3</td>
</tr>
<tr>
<td align="left" valign="top">Natural killer cell mediated cytotoxicity</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">0.022</td>
<td align="left" valign="top">PRF1, LCK, ZAP70, PAK1, FAS</td>
</tr>
<tr>
<td align="left" valign="top">Fructose and mannose metabolism</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">0.032</td>
<td align="left" valign="top">PFKFB4, HK3, AKR1B1</td>
</tr>
<tr>
<td align="left" valign="top">Primary immunodeficiency</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">0.036</td>
<td align="left" valign="top">CD8B, LCK, ZAP70</td>
</tr>
<tr>
<td align="left" valign="top">Fc gamma R-mediated phagocytosis</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">0.038</td>
<td align="left" valign="top">HCK, SPHK1, PAK1, CRK</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn3-mmr-18-03-2789"><p>Count of genes denotes the number of genes significantly associated with each KEGG pathway. KEGG, Kyoto Encyclopedia of Genes and Genomes.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>